Abeona Therapeutics Inc. share price logo

Abeona Therapeutics Inc. Share Price

NASDAQ: ABEO

Small Cap

$4.56

+0.01

(+0.22%)

as on

Abeona Therapeutics Inc. Stock Performance

as on March 20, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.47
    $4.62
    downward going graph

    1.97%

    Downside

    1.32%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.93
    $7.54
    downward going graph

    13.75%

    Downside

    65.35%

    Upside

    downward going graph

Abeona Therapeutics Inc. share price movements today

Previous Close
$4.55
Open
$4.50
Volume
1.2M
Day's Low - High
$4.47 - $4.62
52 Week Low - High
$3.93 - $7.54

Abeona Therapeutics Inc. Historical Returns

1 Month Return
-13.99 %
3 Month Return
-10.96 %
1 Year Return
-12.5 %
3 Year Return
+ 90.38 %
5 Year Return
-91.65 %

Abeona Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Abeona Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$258.0M

EPS (TTM)

-0.41

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

3.93

Industry PE ratio

-1.319090909090909

PEG Ratio

0

EBITDA

-86.9M

Revenue (TTM)

5.8M

Profit Margin

1223.08%

Return On Equity TTM

70.05%

Abeona Therapeutics Inc. Stock Valuation

Track how Abeona Therapeutics Inc. P/E has moved over time to understand its valuation trends.

Abeona Therapeutics Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-9.23x)

September 30, 2023

Industry (-1.32x)

March 19, 2026

Today (3.93x)

March 19, 2026

Highest (6.78x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 3.93x

Abeona Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abeona Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Abeona Therapeutics Inc. image
Abeona Therapeutics Inc.
BUY$258.0M-91.65%3.931223.08%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.5B118.37%136.938.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$117.5B108.96%30.2132.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$33.2BNA116.335.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.2B57.09%18.3231.41%

Stock Returns calculator for Abeona Therapeutics Inc. Stock including INR - Dollar returns

The Abeona Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Abeona Therapeutics Inc. investment value today

Current value as on today

₹95,655

Returns

₹4,345

(-4.35%)

Returns from Abeona Therapeutics Inc. Stock

₹12,308 (-12.31%)

Dollar Returns*

₹7,962 (+7.96%)

Analyst Recommendation on Abeona Therapeutics Inc. Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Abeona Therapeutics Inc.. Average target price of $21.07

Abeona Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Abeona Therapeutics Inc..

What analysts predicted

78.36%UPSIDE

Target Price

$21.07

Current Price

$4.56

Analyzed by

9 Analysts

Target

$21.07

Abeona Therapeutics Inc. target price $21.07, a slight upside of 78.36% compared to current price of $4.56. According to 9 analysts rating.

Abeona Therapeutics Inc. Stock’s Investor Sentiment and Interest

Search interest for Abeona Therapeutics Inc. Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-51% versus previous 30 day period

Abeona Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
2
-
-
-
4
-
0
-
5
Gross Profit
0
0
0
0
0
0
0
0
0
1
Operating Income
-11
-13
-14
-17
-15
-16
-19
-22
-24
-22
EBITDA
-10
-15
-29
9
-28
-7
-10
126
-18
-183
Interest Expense
0
0
0
1
1
1
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-11
-16
-31
7
-30
-9
-12
124
-20
-20
Income Tax Expense
0
0
0
-1
-
0
-
15
-15
0
Net Income
-11
-16
-31
7
-30
-9
-12
108
-5
-20
Net Profit Margin
0.00%
-587.50%
0.00%
0.00%
0.00%
-194.33%
0.00%
27208.25%
0.00%
-377.49%

Abeona Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
2
-
10
3
1
3
-
5
Gross Profit
-9
-16
-35
-48
10
3
0
1
-2
4
Operating Income
-23
-27
-58
-77
-81
-89
-50
-47
-64
-89
EBITDA
-21
-26
-54
-69
-74
-76
-34
-50
-56
-85
Interest Expense
0
0
0
0
4
3
0
0
4
3
Depreciation
-
0
2
7
4
3
4
3
2
-
Income Before Tax
-21
-27
-56
-76
-84
-84
-39
-54
-63
71
Income Tax Expense
2
0
1
0
4
3
-7
3
-
0
Net Income
-21
-27
-56
-76
-84
-84
-39
-54
-63
71
Net Profit Margin
-2460.40%
-3263.92%
-1890.29%
0.00%
-842.34%
-2831.20%
-2807.36%
-1548.23%
0.00%
1223.08%

Abeona Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-16
-31
7
-30
-9
-12
108
-5
-20
Operating Cash Flow
-9
-14
-12
-12
-16
-18
-18
-21
-17
Investing Cash Flow
11
-7
-44
-6
18
4
155
-64
9
Financing Cash Flow
7
25
73
0
5
6
10
5
3
Change in Cash
9
3
16
-18
7
-7
147
-80
-4

Abeona Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-27
-56
-76
-84
-84
-39
-54
-63
71
Operating Cash Flow
-22
-39
-62
-35
-65
-43
-37
-56
-76
Investing Cash Flow
0
-85
59
-83
66
-23
0
-39
105
Financing Cash Flow
92
5
113
1
24
43
37
104
26
Change in Cash
68
-118
111
-116
25
-24
0
8
54

Global Institutional Holdings in Abeona Therapeutics Inc.

Funds
Holdings
AIGH Capital Management, LLC
3.69%
Adage Capital Partners Gp LLC
5.99%
Millennium Management LLC
1.31%
Bank of America Corp
1.68%
Awm Investment Company Inc
1.43%
See all

Insights on Abeona Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ABEO has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 24.2% return, outperforming this stock by 36.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ABEO stock has moved down by -8.2%

About Abeona Therapeutics Inc.

abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t
OrganisationAbeona Therapeutics Inc.
Headquarters6555 Carnegie Avenue, Cleveland, OH, United States, 44103
IndustryHealth Technology
CEODr. Vishwas Seshadri M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Abeona Therapeutics Inc.

Name

Title

Dr. Vishwas Seshadri M.B.A., Ph.D.

President, CEO & Director

Mr. Brian Kevany Ph.D.

Chief Technical & Scientific Officer

Dr. Madhav Vasanthavada M.B.A., Ph.D.

Chief Commercial Officer

Mr. Carl Denny

Senior Vice President of Regulatory Affairs

Ms. Megan Callan

Vice President & Head of Quality

Mr. Joseph Walter Vazzano CPA

Chief Financial Officer

Dr. Brendan M. O'Malley J.D., Ph.D.

Chief Legal Officer

Mr. Gregory Gin

Vice President of Investor Relations & Corporate Communications

Ms. Alison Hardgrove

Chief People Officer

Mr. Jon Voss

VP & Head of Quality

FAQs

What is Abeona Therapeutics Inc. share price today?

Abeona Therapeutics Inc. share price today is $4.56 as on at the close of the market. Abeona Therapeutics Inc. share today touched a day high of $4.62 and a low of $4.47.

What is the 52 week high and 52 week low for Abeona Therapeutics Inc. share?

Abeona Therapeutics Inc. share touched a 52 week high of $7.54 on and a 52 week low of $3.93 on . Abeona Therapeutics Inc. stock price today i.e. is closed at $4.56,which is 39.52% down from its 52 week high and 15.95% up from its 52 week low.

What is Abeona Therapeutics Inc.'s market capitalisation today?

Abeona Therapeutics Inc. market capitalisation is $0.00T as on .

How to invest in Abeona Therapeutics Inc. Stock (ABEO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Abeona Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abeona Therapeutics Inc. Shares that will get you 0.3289 shares as per Abeona Therapeutics Inc. share price of $4.56 per share as on March 20, 2026 at 1:29 am IST.

What is the minimum amount required to buy Abeona Therapeutics Inc. Stock (ABEO) from India?

Indian investors can start investing in Abeona Therapeutics Inc. (ABEO) shares with as little as ₹93.193 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.93 in Abeona Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Abeona Therapeutics Inc. share’s latest price of $4.56 as on March 20, 2026 at 1:29 am IST, you will get 2.1930 shares of Abeona Therapeutics Inc.. Learn more about fractional shares .

What are the returns that Abeona Therapeutics Inc. has given to Indian investors in the last 5 years?

Abeona Therapeutics Inc. stock has given -91.65% share price returns and 27.41% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?